Locus Biosciences—a clinical-stage biotech developing a new class of CRISPR-based antibacterial drugs—just closed a $35 million financing round with backing from Johnson & Johnson. The $35 million ...
When something goes wrong, it’s natural to cast blame on the perceived cause of the misfortune. Where an individual casts that blame can be related, in many cases, to a psychological construct known ...
In psychology, it’s almost universally accepted that we want people to have an internal locus of control. The alternative? An external locus of control. Source: Photo by Milad Fakurian on Unsplash ...
RESEARCH TRIANGLE PARK, N.C., October 28, 2025--(BUSINESS WIRE)--Locus Biosciences, Inc. ("Locus"), a clinical-stage biotechnology company developing precision engineered bacteriophage treatments for ...
Who controls your happiness? Who is responsible for your income? Your attitude? Each of us has a belief about how much control we have over the things we encounter in life. We each view life either as ...
Place a finger on the back of your skull, at a point roughly level with the tops of your ears. Here, deep beneath the hair, skin and bone, near a fluid-filled cavity in the root of your brain, lies a ...
Massachusetts-based Locus Robotics today announced a $150 million Series E. The round, led by Tiger Global Management and Bond, brings the firm’s total to around $250 to date, and values the robotics ...
A group of investors in Locus Solutions, a biotechnology company headquartered in Solon, is accusing some of the business’ key leaders of fraud, “operational incompetence” and running the business to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback